logo
  

Lonza Group Updates Mid-Term Guidance - Quick Facts

At Capital Markets Day 2021, Lonza Group (LZAGF.PK) stated that all divisions are growing ahead of their reference markets, building on growth investments and innovation. The Biologics division remains the primary driver for growth, the company noted.

Also, Lonza has updated its 2024 Group and divisional mid-term guidance driven by strong momentum across businesses. At a Group level, the company anticipates: low-teens CER sales growth; core EBITDA margin of around 33% to 35%; and double-digit ROIC.

Lonza said it is accelerating de-risked long-term investment program. These investments will allow the company to drive strong growth in the mid-to-long term. The company projects full year 2021 CAPEX to reach around 25% of sales and remain elevated at current levels for the next few years, returning to high-teens by 2025.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Goldman Sachs Group, Inc. (GS) reported that its third quarter net earnings applicable to common shareholders increased 63 percent year-on-year. Net revenues were also significantly higher reflecting significantly higher net revenues in Investment Banking, Global Markets and Consumer & Wealth Management,... Butterball, LLC recalled about 14,107 pounds of ground turkey products for potential contamination with foreign materials, specifically blue plastic material, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) said in a statement. Specialized Bicycle Components, Inc. is recalling about 6,900 units of Tarmac SL7 Bicycles and Framesets for potential risk of fall and injury hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the bicycle's fork steerer tube can crack or break after harsh impact such as hitting a deep pothole or other stress event, posing fall and injury hazards.
Follow RTT